| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2007;38:794.)
© 2007 American Heart Association, Inc.
New Approaches to Clinical Trials in Neuroprotection: Introduction |
From the Department of Neuroscience, University of California, San Diego (T.M.F., P.D.L.), and Department of Veterans Affairs, San Diego, Calif (P.D.L.).
Correspondence to Thomas M. Hemmen, MD, PhD, Department of Neuroscience, University of California, San Diego, 200 W Arbor Dr, MC 8466, OPC 3rd Floor, Suite 3, San Diego, CA 92103-8466. E-mail themmen{at}ucsd.edu
Abstract
Induced hypothermia is one of the most promising neuroprotective therapies. Technological limitations and homeostatic mechanisms that maintain core body temperature have impeded the clinical use of hypothermia. Recent advances in intravascular cooling catheters and successful trials of hypothermia for cardiac arrest and neonatal asphyxia renewed interest in hypothermia for stroke, resulting in early phase clinical trials and plans for further development. This review elaborates on the clinical implications of hypothermia research in stroke and technical and logistical issues associated with the application of hypothermia.
Key Words: acute care hypothermia neuroprotection
This article has been cited by other articles:
![]() |
H. M. den Hertog, H. B. van der Worp, H. M. van Gemert, and D. W. Dippel Acetaminophen for Temperature Reduction in Acute Stroke: Potential but Unproven Benefits Stroke, November 1, 2007; 38(11): e131 - e131. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |